UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056145
Receipt number R000063528
Scientific Title Comparison of complications associated with noradrenaline administered into central venous catheters and peripheral venous access: a scoping review.
Date of disclosure of the study information 2024/11/13
Last modified on 2024/11/13 14:52:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of complications associated with noradrenaline administered into central venous catheters and peripheral venous access: a scoping review.

Acronym

Comparison of complications associated with noradrenaline administered into CVCs and PiVCs: a ScR.

Scientific Title

Comparison of complications associated with noradrenaline administered into central venous catheters and peripheral venous access: a scoping review.

Scientific Title:Acronym

Comparison of complications associated with noradrenaline administered into CVCs and PiVCs: a ScR.

Region

Japan


Condition

Condition

Shock

Classification by specialty

Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to systematically map and compare what is known in the existing literature regarding the early and late complications of peripherally versus centrally administered noradrenaline.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Early and late complications of noradrenaline administered via peripheral and central venous catheters and related existing research findings

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

A literature search of Pubmed, Medline, the Cochrane Library, Web of science, and CINAHL will be used to identify literature regarding peripheral versus central venous administration of noradrenaline and norepinephrine and complications.

Key exclusion criteria

The candidates that came up from each search site were some that had been tested on animals, some that were administered via routes other than intravenous administration, and some that were being evaluated in combination with other drugs.

Target sample size



Research contact person

Name of lead principal investigator

1st name Yutaka
Middle name
Last name Kumaido

Organization

Saitama Medical Center, Jichi Medical University

Division name

Department of Emergency and Critical Care Medicine

Zip code

330-0834

Address

1-847 Amanuma-cho, Omiya-ku, Saitama-shi, Saitama-ken, Japan

TEL

+81-48-647-2111

Email

kumaido.yutaka@jichi.ac.jp


Public contact

Name of contact person

1st name Yutaka
Middle name
Last name Kumaido

Organization

Saitama Medical Center, Jichi Medical University

Division name

Department of Emergency and Critical Care Medicine

Zip code

330-0834

Address

1-847 Amanuma-cho, Omiya-ku, Saitama-shi, Saitama-ken, Japan

TEL

+81-48-647-2111

Homepage URL


Email

kumaido.yutaka@jichi.ac.jp


Sponsor or person

Institute

Other

Institute

Department

Personal name

Yutaka Kumaido


Funding Source

Organization

Other

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical Center, Jichi Medical University

Address

1-847 Amanuma-cho, Omiya-ku, Saitama-shi, Saitama-ken, Japan

Tel

+81-48-647-2111

Email

kumaido.yutaka@jichi.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 11 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

4099

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 09 Month 19 Day

Date of IRB

2024 Year 09 Month 19 Day

Anticipated trial start date

2024 Year 09 Month 19 Day

Last follow-up date

2025 Year 03 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2024 Year 11 Month 13 Day

Last modified on

2024 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063528